Daniel Devriendt

Erasmus Hospital

Papers

2

Total Citations

21

H-Index

2

About

Daniel Devriendt is a leading neurosurgeon and researcher specializing in the stereotactic radiosurgery of complex skull base and inner ear tumors, with a particular focus on neurofibromatosis type 2 (NF2) and rare schwannomas. His major contributions center on demonstrating that Gamma Knife radiosurgery can achieve high rates of tumor control while preserving critical neurological function, especially hearing, in patients who are often poor candidates for conventional surgery. In his landmark 2013 study on NF2-related vestibular schwannomas, Devriendt showed that precise, robotized irradiation could control tumor growth while maintaining serviceable hearing in a significant proportion of patients—a finding that has shaped modern treatment paradigms for this challenging genetic disorder. His earlier work on intralabyrinthine schwannomas (2011) was equally pioneering, establishing radiosurgery as a safe, minimally invasive alternative for tumors arising within the cochleo-vestibular structures. With over 20 citations across his most influential papers, Devriendt’s research has had a direct impact on clinical practice, offering patients with these rare tumors a chance at long-term tumor control without sacrificing quality of life. His meticulous approach to dose planning and functional preservation continues to influence the field of stereotactic radiosurgery.

Research Focus

Key Achievements

2
H-Index
2
Papers
21
Total Citations
11
Avg Citations/Paper
🏆 Most Cited Paper
Hearing preservation and tumour control after radiosurgery for NF2-related vestibular schwannomas.
12 citations · 2013
📈 Most Prolific Year: 2013 (1 Papers)
🤝 Key Collaborators: 8
🏛 Institutions: Erasmus Hospital

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago